SAHPRA GMP Compliance: Addressing Allegations A...

By HEOR Staff Writer

February 25, 2026

SAHPRA GMP compliance at Adcock Ingram's Clayville facility has been reaffirmed by the South African Health Products Regulatory Authority (SAHPRA) in its
Pharmaceutical Tender Investigation Sparks Regulatory Scrutiny in South Africa
South Africa Health Reform: Navigating Innovations and Challenges for 2026
Enhancing Patient Safety in Africa’s Healthcare Transformation
Navigating Economic Resilience Through Life Sciences Investment
Driving Economic Transformation through Brain Health Investment in Africa
mRNA Vaccine Advancements: Transforming Infectious Disease Prevention and Equity
Africa Medicine Roadmap: Paving the Way for Sustainable Access to Quality Pha...
AI in South African Healthcare: Professionals’ Confidence in Reducing A...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Aligning Medical Schemes with National Health Insurance South Africa